The hospital chain’s shares closed Feb. 20 at $6.72, their highest closing price since October 2017. Shares of CHS traded between $5.39 and $7.26 on Feb. 20 and were up 40 percent from the day prior at market close.
The big jump came after CHS reported fourth-quarter operating revenues of $3.29 billion, surpassing the Wall Street consensus estimate of $3.18 billion. The company reported adjusted earnings per share of 40 cents for the fourth quarter of 2019, topping analysts’ average estimate of a loss of 46 cents per share, according to The Motley Fool.
More articles on healthcare finance:
How a Massachusetts hospital’s faulty data slashed Medicare payments statewide
Board member bankrolls hospital operator with $17M in loans
Americore CEO to surrender management of hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.